|
Palo Alto, CA – October 22, 2008 – Telik, Inc. (Nasdaq: TELK) announced that its 2008 third quarter conference call and webcast will be held on Wednesday, November 5, 2008 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) following the release earlier that day of the company’s financial results for the third quarter ended September 30, 2008.
The conference call will be accessible via Telik’s website at www.telik.com or by telephone at 800-398-9367 or 612-332-7517. An archive of the conference call will be available on the Telik website or by telephone at 800-475-6701 or 320-365-3844, access code 966597. The archive will be available from approximately 6:00 p.m. Eastern time on November 5 through November 19, 2008.
Telik, Inc. of Palo Alto, CA, is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company’s most advanced investigational drug candidates in clinical development are TELINTRA ®, a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA ®, a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP ®, which enables the rapid and efficient discovery of small molecule drug candidates.
TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.
###
Contact:
Patricia P. Frias
Corporate Communications
Telik, Inc.
Tel: 650 845 7927
Email: pfrias@telik.com
Go to: 2008 Press Releases
2007
Press Releases
2006
Press ReleasesEvents |
TELIK ANNOUNCES 2008 THIRD QUARTER FINANCIAL RELEASE, CONFERENCE CALL AND WEBCAST
